Synergy of Pancratistatin and Tamoxifen in inducing apoptosis in breast cancer cells

Cancer Biology and Therapy

Volumn 7, Issue 3, 2008, Pages 385-386

  Ray, Sidhartha ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT; PANCRATISTATIN; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; HUMAN; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NOTE;

EID: 45349094289     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.3.5797     Document Type: Note

References (22)

1. McLachlan A, Kekre N, McNulty J, Pandey S. Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis 2005; 10: 619-30.
2. Kekre N, Griffin C, McNulty J, and Pandey S. Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemotherapy and Pharmacology 2005; 56: 29-38.
3. McNulty J, Larichev V, Pandey S. A synthesis of 3- deoxydihydrolycoricidine: Refinement of a structurally minimum Pancratistatin parmacophore. Bioorg. & Med. Chem. Lett. 2005; 15:5315-8.
4. Pandey S, Kekre N, Naderi J, McNulty J. Induction of Apoptotic Cell Death Specifically in Rat and Human Cancer Cells by Pancratistatin. Artificial Cells, Blood Substitutes, & Biotechnology 2005; 33:279-95.
5. Griffin C, Sharda N, Sood D, Nair J, McNulty J, Pandey S. Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds. Cancer Cell Int. 2007; 7:10.
6. Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and Human Cancer. Curr Mol Med. 2007; 7:121-31.
7. Heerdt AS, Borgan PI. Current status of Tamoxifen use: An update for the surgical oncologist. Journal of Surgical Oncology 1999; 72: 42-9.
8. Mandlekar S, Kong ANT. Mechanisms of Tamoxifen-induced apoptosis. Apoptosis 2001; 6: 469-77.
9. C. Tuquet, J. Dupont, A. Mesneau and J. Roussaux. Effects of tamoxifen on the electron transport chain of isolated rat liver Mitochondria. Cell Biology and Toxicology. 2000; 16: 207-19.
10. Moreira P, Custodio J, Morena A, Oliveira C, Santos M. Tamoxifen and Estradiol interact with the flavin mononucleotide site of mitochondrial complex 1 leading to mitochondrial failure. Journal of Biological Chemistry 2006; 281:10143-52.
11. Nazarewicz RR, Zenebe WJ, Parihar A, Larson SK, Alidema E, Choi J, Ghafourifar P. Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res 2007; 67:1282-90
12. Kallio A, Zheng A, Dahllund J, Heiskanen KM, Harkonen P. Role of mitochondria in Tamoxifen-induced cancer cells. Apoptosis 2005; 10:1395-410.
13. Anderson WM, Delinck DL, Benninger L, Wood JM, Smiley ST, Chen LB. Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes. Biochem. Pharmacol. 1993; 45:691-6.
14. Bleday R, Weiss MJ, Salem RR, Wilson RE, Chen LB, Steele Jr. G. Inhibition of rat colon tumor isograft growth with dequalinium chloride. Arch. Surg. 1986; 121: 1272-5.
15. Weiss MJ, Wong JR, Ha CS, Bleday R, Salem RR, Steele Jr., GD, Chen LB, Dequalinium A. A topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc. Natl Acad. Sci. USA 1987; 84: 5444-8.
16. Sun X, Wong JR, Song K, Hu J, Garlid KD, Chen LB. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. Cancer Res. 1994; 54:465-1471.
17. Koya K, Li Y, Wang H, Ukai T, Tatsuta N, Kawakami M, Shishido s, Chen LB. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity inpreclinical studies based on selective mitochondrial accumulation. Cancer Res. 1996; 56: 538-43.
18. Rideout D, Bustamante A, Patel J. Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride. Int. J. Cancer 1994; 57:247-53.
19. Modica-Napolitano JS, Koya K, Weisberg E, Brunelli BT, Li Y, Chen LB. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res. 1996; 56: 544-50.
20. Weisberg EL, Koya K, Modica-Napolitano J, Li Y, Chen LB. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res. 1996; 56: 551-5.
21. Weissig V, Torchilin VP. (Eds.), Drug and DNA delivery to mitochondria Adv. Drug Deliv. Rev. 2001; 49, pp. 1-2. PubMed
22. Modica-Napolitano JS, Singh KK, Mitochondria as targets for the detection and treatment of cancer. Exp. Rev. Mol. Med. 2002; 4: 1-19.